Pharma Diary. The European Medicines Agency (EMA) has so far authorized a total of 19 biosimilars of seven different active substances belonging to 11 different companies or business groups, according to the information registered by the EMA on its website.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
